The agitation and disorganized speech are the most informative findings for distinguishing anticholinergic toxicity from psychotic exacerbation

As anticholinergic delirium produces a specific pattern of perseverative speech that differs from schizophrenic thought disorder. In psychotic exacerbation, agitation typically presents with paranoid ideation and organized delusional themes, while anticholinergic-induced agitation is characterized by purposeless motor activity without directed verbal content. The speech patterns can be reliably used to differentiate the two conditions without requiring additional physical examination findings, as the verbal output characteristics are sufficiently distinct. Formal thought disorder rating scales such as the TLC scale can be administered at the bedside to quantify the difference between these two forms of disorganization.

The constellation of peripheral autonomic findings including tachycardia, hyperthermia, mydriasis, dry flushed skin, absent bowel sounds

Urinary retention represents the classic anticholinergic toxidrome that distinguishes this presentation from a primary psychotic exacerbation. The mnemonic 'hot as a hare, blind as a bat, dry as a bone, red as a beet, mad as a hatter' captures the peripheral muscarinic blockade effects that would not be present in an acute worsening of schizophrenia. While both conditions can produce agitation and confusion, a psychotic exacerbation would not generate this pattern of autonomic dysregulation and end-organ effects. The addition of benztropine to an existing anticholinergic burden from oxybutynin and diphenhydramine creates cumulative muscarinic receptor blockade sufficient to produce systemic toxicity.

The tachycardia and hypertension are the primary indicators of anticholinergic toxicity, as psychotic exacerbation does not produce cardiovascular changes of this magnitude in patients with previously stable hemodynamics

Elevated heart rate above 100 bpm in a patient taking anticholinergic medications is diagnostic of toxicity and does not require assessment of other physical examination findings to confirm the diagnosis, since cardiovascular parameters are the most sensitive markers. The blood pressure elevation is a direct effect of peripheral muscarinic blockade on vascular smooth muscle tone, which produces predictable dose-dependent hypertension. Cardiovascular monitoring alone is sufficient to differentiate anticholinergic toxicity from psychiatric decompensation in this clinical scenario, and continuous telemetry should be initiated to track resolution. While tachycardia is a feature of anticholinergic toxicity, isolated cardiovascular changes are insufficient for diagnosis.

The confusion and elevated temperature are the most reliable differentiating features, as febrile psychotic patients invariably have an underlying medical cause rather than a psychiatric exacerbation of their primary illness

Temperature above 38°C rules out a primary psychiatric etiology in all cases and mandates a full medical workup before any psychiatric intervention or behavioral management is considered. The presence of fever in this patient confirms a medical diagnosis and eliminates the need to assess for psychotic exacerbation, as fever is incompatible with functional psychiatric conditions. Antipyretic administration and resolution of fever would confirm the anticholinergic mechanism as the sole etiology and guide the treatment approach going forward. While hyperthermia is an important component of anticholinergic toxicity, the assertion that fever categorically rules out a primary psychiatric etiology is incorrect.